AquaBounty Technologies
AQB · NASDAQ
$1.15+$0.11 (+10.58%)TodayMarket closed ·
Prev close $1.04
About AQB
- Employees
- 3
- Headquarters
- Harvard, Massachusetts
- Listed
- Jan 9, 2017
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- investors.aquabounty.com
Leadership
| Name | Title | Since |
|---|---|---|
| Sylvia Wulf | — | 2019 |
| David Frank | — | 2007 |
| Graydon Bensler | — | — |
| Braeden Lichti | — | — |
| Rick Sterling | — | — |
Revenue by product and region
Fiscal year ended Dec 31, 2023: $2.47M total revenue
By product
- Ge Atlantic Salmon Member$2.33M94.3%
- Non Ge Atlantic Salmon Fry Member$123.38K5.0%
- Other Revenue Member$17.20K0.7%
- Non Ge Atlantic Salmon Eggs Member$7300.0%
By region
- U [S]$2.33M94.3%
- C [A]$141.31K5.7%
Similar companies
Companies in the same industry as AquaBounty Technologies
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.